BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26749261)

  • 1. First trimester screening cut-offs for noninvasive prenatal testing as a contingent screen: Balancing detection and screen-positive rates for trisomy 21.
    Maxwell S; James I; Dickinson JE; O'Leary P
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):29-35. PubMed ID: 26749261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance and costs of contingent screening models for trisomy 21 incorporating non-invasive prenatal testing.
    Maxwell S; O'Leary P; Dickinson JE; Suthers GK
    Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):432-439. PubMed ID: 28369759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective assessment of the Hong Kong Hospital Authority universal Down syndrome screening programme.
    Sahota DS; Leung WC; Chan WP; To WW; Lau ET; Leung TY
    Hong Kong Med J; 2013 Apr; 19(2):101-8. PubMed ID: 23535668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
    Kagan KO; Cicero S; Staboulidou I; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Mar; 33(3):259-64. PubMed ID: 19248005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester contingent testing with either nuchal translucency or cell-free DNA. Cost efficiency and the role of ultrasound dating.
    Conner P; Gustafsson S; Kublickas M
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):368-75. PubMed ID: 25581307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of introducing combined first-trimester trisomy 21 screening in the French population.
    Royère D;
    Eur J Public Health; 2016 Jun; 26(3):492-7. PubMed ID: 26628633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
    O'Leary P; Maxwell S; Murch A; Hendrie D
    Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population.
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialard F; Giudicelli Y; Ville Y
    Am J Obstet Gynecol; 2006 Nov; 195(5):1379-87. PubMed ID: 16723105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential and contingent prenatal screening for Down syndrome.
    Wald NJ; Rudnicka AR; Bestwick JP
    Prenat Diagn; 2006 Sep; 26(9):769-77. PubMed ID: 16821246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome.
    Kou KO; Poon CF; Kwok SL; Chan KY; Tang MH; Kan AS; Leung KY
    Hong Kong Med J; 2016 Jun; 22(3):223-30. PubMed ID: 27149976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort.
    Li SW; Barrett AN; Gole L; Tan WC; Biswas A; Tan HK; Choolani M
    Singapore Med J; 2015 Jan; 56(1):47-52. PubMed ID: 25640099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential pathways of testing after first-trimester screening for trisomy 21.
    Platt LD; Greene N; Johnson A; Zachary J; Thom E; Krantz D; Simpson JL; Silver RK; Snijders RJ; Goetzl L; Pergament E; Filkins K; Mahoney MJ; Hogge WA; Wilson RD; Mohide P; Hershey D; MacGregor S; Bahado-Singh R; Jackson LG; Wapner R;
    Obstet Gynecol; 2004 Oct; 104(4):661-6. PubMed ID: 15458882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing.
    Nicolaides KH; Wright D; Poon LC; Syngelaki A; Gil MM
    Ultrasound Obstet Gynecol; 2013 Jul; 42(1):41-50. PubMed ID: 23744626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contingent screening for Down syndrome completed in the first trimester: a multicenter study.
    Muñoz-Cortes M; Arigita M; Falguera G; Seres A; Guix D; Baldrich E; Acera A; Torrent A; Rodriguez-Veret A; Lopez-Quesada E; Garcia-Moreno R; Gonce A; Borobio V; Borrell A
    Ultrasound Obstet Gynecol; 2012 Apr; 39(4):396-400. PubMed ID: 21674658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.